Myocardial Infarction, AcuteAsan-MINCT03412435
Asan Medical Center Myocardial Infarction Registry
An observational study of Myocardial Infarction, Acute and Coronary Stenosis, run by Seung-Jung Park at 1 site in South Korea.
Trial summary
This study evaluates long-term outcome of patients diagnosed as acute myocardial infarction and treated with medication, coronary artery bypass surgery and percutaneous coronary intervention in Asan medical center, Korea. Read more about this study
- Who is it for?
- Ages 19 years and older
- Conditions the study is for
- Myocardial Infarction, Acute, Coronary Stenosis
- How many people
- 5,000 participants
- Where
- 1 siteSouth Korea
- Study dates
- 27 Apr 2018to 31 Dec 2031
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 19 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: All consecutive acute myocardial infarction patients diagnosed through coronary angiography
Who may be able to join
- All consecutive acute myocardial infarction patients diagnosed through coronary angiography
Who cannot join
None listed.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Seung-jung Park, MD contact
South Korea1 site, 1 recruiting
- Recruiting
Asan Medical Center
Seoul
Seung-jung Park, MD, sjpark@amc.seoul.kr
Seung-jung Park, MD
About this study
This study evaluates long-term outcome of patients diagnosed as acute myocardial infarction and treated with medication, coronary artery bypass surgery and percutaneous coronary intervention in Asan medical center, Korea.
Read the detailed description
This study will collect 3000 cases retrospectively and 2000 cases prospectively.
- Conditions
- Myocardial Infarction, Acute, Coronary Stenosis
- Keywords
- Acute myocardial infarction, Myocardial infarction
- Medical subject headings
- Myocardial Infarction, Coronary Stenosis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Myocardial infarction | diagnosed as acute myocardial infarction and treated with medical treatment, coronary artery bypass surgery and percutaneous coronary intervention. |
What is being measured
The primary outcome is the main question the study is designed to answer.
A composite event of all-cause death, non-fatal myocardial infarction and repeat revascularization
Measured: 1 year
Secondary outcomes (10)
All cause death
Measured: 5 year
Cardiac death
Measured: 5 year
Myocardial infarction
Measured: 5 year
A composite event of all-cause death and myocardial infarction
Measured: 5 year
A composite event of cardiac death and myocardial infarction
Measured: 5 year
Repeat revascularization
Measured: 5 year
Stent thrombosis
according to Academic Research Consortium (ARC) criteria
Measured: 5 year
Stroke
A stroke or cerebrovascular accident with loss of neurological function caused by an ischemic or hemorrhagic event with residual symptoms at least 24 hours after onset or leading to death.
Measured: 5 year
Procedure success
Successful percutaneous coronary intervention at the intended target lesion with final instant residual stenosis of less than 30% by quantitative coronary angiography (QCA) and no event of death or Q wave myocardial infarction or urgent revascularization during hospitalization.
Measured: 7 days
Surgery success
Successful surgery defines as no event of death or Q wave myocardial infarction or urgent revascularization during hospitalization.
Measured: 7 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Jan 2018
- Study start27 Apr 2018
- Primary completion31 Dec 2026 (estimated)
- Study completion31 Dec 2031 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Myocardial Infarction, AcuteStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 5,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Seung-Jung Park
- Sponsor type
- University, hospital or other
- Collaborators
- CardioVascular Research Foundation, Korea
- Responsible party
- Sponsor-investigator, Seung-Jung Park, Asan Medical Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03412435
- Sponsor's protocol ID
- AMCCV2018-01
- Acronym
- Asan-MI
- Status last verified
- Dec 2025
- First submitted
- 21 Jan 2018
- Last updated
- 2 Jan 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 2 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Asan Medical Center Myocardial Infarction Registry
- ClinicalTrials.gov ID
- NCT03412435
- Acronym / sponsor ID
- Asan-MI / AMCCV2018-01
- Conditions
- Myocardial Infarction, Acute, Coronary Stenosis
- Keywords
- Acute myocardial infarction, Myocardial infarction
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 5,000 participants (estimated)
- Lead sponsor
- Seung-Jung ParkUniversity, hospital or other
- Collaborators
- CardioVascular Research Foundation, Korea
- Study start
- 27 Apr 2018 (actual)
- Primary completion
- 31 Dec 2026 (estimated)
- Study completion
- 31 Dec 2031 (estimated)
- First posted
- 26 Jan 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study evaluates long-term outcome of patients diagnosed as acute myocardial infarction and treated with medication, coronary artery bypass surgery and percutaneous coronary intervention in Asan medical center, Korea.
Detailed description
This study will collect 3000 cases retrospectively and 2000 cases prospectively.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Myocardial infarction | – | –diagnosed as acute myocardial infarction and treated with medical treatment, coronary artery bypass surgery and percutaneous coronary intervention. |
Who may qualify
- Ages
- 19 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- All consecutive acute myocardial infarction patients diagnosed through coronary angiography
Key inclusion criteria (1 listed)
- All consecutive acute myocardial infarction patients diagnosed through coronary angiography
Key exclusion criteria (0 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
A composite event of all-cause death, non-fatal myocardial infarction and repeat revascularization
Time frame: 1 year
10 secondary outcomes
All cause death
Time frame: 5 year
Cardiac death
Time frame: 5 year
Myocardial infarction
Time frame: 5 year
A composite event of all-cause death and myocardial infarction
Time frame: 5 year
A composite event of cardiac death and myocardial infarction
Time frame: 5 year
Repeat revascularization
Time frame: 5 year
Stent thrombosis
Time frame: 5 year
Stroke
Time frame: 5 year
Procedure success
Time frame: 7 days
Surgery success
Time frame: 7 days
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Jan 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Myocardial Infarction, Acute
Not yet recruitingObservational study
Elicit Drugs in Myocardial Infarction
Young Patients With Acute Myocardial Infarction
Recruiting
CT Stress Myocardial Perfusion, Fractional Flow Reserve and Angiography in Patients With Stable Chest Pain Syndromes
Coronary Artery Disease, Chest Syndrome
RecruitingPhase 4
Early Single Antiplatelet Therapy After IVUS-Guided PCI in Acute Coronary Syndrome
Acute Coronary Syndromes, STEMI
Recruiting
Heart@Home Safety and Efficacy of Hospital-at-Home Care Versus Standard Hospitalization in Cardiac Patients
Myocardial Infarction, Myocarditis Acute
Enrolling by invitationPhase 3
Selatogrel Outcome Study in Suspected Acute Myocardial Infarction
Acute Myocardial Infarction
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Seung-jung Park, MD contact
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Myocardial Infarction, Acute and Coronary Stenosis, run by Seung-Jung Park at 1 site in South Korea.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 2 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Seung-jung Park, MD (sjpark@amc.seoul.kr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
A composite event of all-cause death, non-fatal myocardial infarction and repeat revascularization (time frame: 1 year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jan 2026.